A new cytotoxin specific for the target cells of corticotropin-releasing factor

J SCHWARTZ, B PENKE, J RIVIER, W VALE - Endocrinology, 1987 - academic.oup.com
J SCHWARTZ, B PENKE, J RIVIER, W VALE
Endocrinology, 1987academic.oup.com
To develop a cytotoxic agent selective for pituitary corticotropes, an analog of CRF,[Nle21,
38, Arg36] rat (r) CRF, was conjugated to the plant toxin gelonin using glutaraldehyde as a
cross-linking agent. In a two-step synthesis, glutaraldehyde was first coupled to the amino-
terminal of the CRF analog. This was then reacted with gelonin to form a product, which
contained 20 mol [Nle21, 38, Arg36] rCRF/mol gelonin, as indicated by amino acid analysis.
Efficacy and specificity of the gelonin-[Nle21, 38, Arg36] rCRF conjugate were assessed in …
Abstract
To develop a cytotoxic agent selective for pituitary corticotropes, an analog of CRF, [Nle21,38, Arg36] rat(r) CRF, was conjugated to the plant toxin gelonin using glutaraldehyde as a cross-linking agent. In a two-step synthesis, glutaraldehyde was first coupled to the amino-terminal of the CRF analog. This was then reacted with gelonin to form a product, which contained 20 mol [Nle21,38, Arg36]rCRF/mol gelonin, as indicated by amino acid analysis. Efficacy and specificity of the gelonin- [Nle21,38, Arg36]rCRF conjugate were assessed in cultured rat anterior pituitary cells 3 days after a 12-h exposure to the cytotoxic conjugate, CRF, or gelonin. While pretreatment with the cytotoxic gelonin-[Nle21,38, Arg36]rCRF conjugate decreased cellular ACTH content by 74%, pretreatment with appropriate concentrations of CRF had no significant effect on cellular ACTH content. The ACTH secretory response to 2.5 nM CRF was completely eliminated by pretreatment with the gelonin- [Nle21,38, Arg36]rCRF conjugate; in contrast, pretreatment with identical doses of CRF had minimal effect. Neither pretreatment with CRF nor pretreatment with the gelonin- [Nle21,38, Arg36] rCRF conjugate had any effect on the content of LH or the LH secretory response to GnRH. These results indicate the efficacy and specificity of the conjugate of [Nle21,38, Arg36]rCRF to gelonin in eliminating CRF target cells. (Endocrinobgy121:1454–1460, 1987)
Oxford University Press